Early-Life Exposure To Microbiota Restricts Colon Cancer Later In Life, Study Finds
Published March 13, 2019 in News Hub
Exposure to microbiota, or microorganisms such as bacteria, in the early stages of life plays a crucial role in establishing optimal conditions in the intestine that inhibit the development of colon cancer in adulthood, according to a study led by Georgia State University.
hivtestube
Problem Drinking Linked To HIV, Other Sexually Transmitted Infections In Ugandan Youth, Study Finds
Published March 12, 2019 in News Hub
Youth living in the slums of Uganda who are infected with both HIV and sexually transmitted infections are more likely to engage in problem drinking, according to a study led by Georgia State University.
flu cells
IBMS Researcher Gets $5 Million Grant To Develop Antiviral Drug to Treat Influenza Virus
Published March 12, 2019 in News Hub
Dr. Richard Plemper, a professor in Georgia State University’s Institute for Biomedical Sciences (IBMS), has received a five-year, $5 million federal grant to develop an antiviral drug to treat influenza virus infections.

Featured Researchers

Research News

Early-Life Exposure To Microbiota Restricts Colon Cancer Later In Life, Study Finds
Published March 13, 2019 in News Hub
Exposure to microbiota, or microorganisms such as bacteria, in the early stages of life plays a crucial role in establishing optimal conditions in the intestine that inhibit the development of colon cancer in adulthood, according to a study led by Georgia State University.
hivtestube
Problem Drinking Linked To HIV, Other Sexually Transmitted Infections In Ugandan Youth, Study Finds
Published March 12, 2019 in News Hub
Youth living in the slums of Uganda who are infected with both HIV and sexually transmitted infections are more likely to engage in problem drinking, according to a study led by Georgia State University.
flu cells
IBMS Researcher Gets $5 Million Grant To Develop Antiviral Drug to Treat Influenza Virus
Published March 12, 2019 in News Hub
Dr. Richard Plemper, a professor in Georgia State University’s Institute for Biomedical Sciences (IBMS), has received a five-year, $5 million federal grant to develop an antiviral drug to treat influenza virus infections.

Featured Researchers